Lei Li
Sidley Austin LLPSidley Austin LLP's lawyers ‘give clients very practical advice’. The practice has a significant market reputation for life sciences regulatory work; and it is home to specialists in licensing-related deals, series financings, M&A, IPOs, and fundraising. The practice additionally assists multinational pharmaceutical and healthcare companies with both government and internal investigations. Chen Yang in Beijing routinely acts for international pharmaceutical, medical device, agricultural, food, and cosmetics companies. Working across the Beijing and Hong Kong offices, Lei Li advises on product registration, clinical trials, distribution, licensing, co-marketing, M&A and spin-offs; and Ruchun Ji acts for emerging and innovative life sciences sector companies throughout their life cycles. Based in Hong Kong and Singapore, Yuet Ming Tham is the firm’s Asia-Pacific compliance and investigations practice head.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Sidley's life sciences team has been deeply involved in the industry for many years and has accumulated rich practical experience in various fields, such as M&A, regulatory, compliance, and antitrust.’
‘Sidley's lawyers give clients very practical advice based on the actual situation of Chinese business, which is very rare.’
‘Chen Yang has extensive experience in the regulatory field.’
‘Lei Li has outstanding experience.’
Key clients
- Connect Biopharma
- Impact Therapeutics
- OnCusp Therapeutics
- Resolian
- RDPAC
- Sanofi Aventis China
- SanReno Therapeutics Holdings
- Takeda China Investment Co
- Zylox-Tonbridge Medical Technology
Work highlights
- Advised Sanofi Aventis China on a successful collaboration with Shanghai Pharma, through which Shanghai Pharma will import, distribute and promote 21 Sanofi drugs.
- Advised RDPAC on the development of three highly influential industry compliance guidelines, including a digital health industry guideline.
- Advised SanReno Therapeutics Holdings on its acquisition by Novartis.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Lei Li, Chen Yang